End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,682 MXN | +0.06% |
|
-0.79% | +1.36% |
01:00pm | New semester, new state of mind | ![]() |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
Official Publications
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Minutes of the general assembly | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
Dividends | CO | |
Acquisition | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJ * Stock
- News Johnson & Johnson
- Official Publications